Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease
- PMID: 18174543
- DOI: 10.1164/rccm.200710-1606OC
Pulmonary hypertension and cor pulmonale during severe acute chest syndrome in sickle cell disease
Abstract
Rationale: Steady-state mild pulmonary hypertension is a risk factor for death in adults with sickle cell disease. Acute pulmonary hypertension has been reported during exercise and vasoocclusive pain crisis in these patients.
Objectives: The aim of the present study was to evaluate changes in pulmonary pressures and cardiac biomarkers during severe acute chest syndrome and their associations with mortality.
Methods: We prospectively evaluated 70 consecutive adults who received standardized treatment in our intensive care unit for a total of 84 episodes. At admission, cardiac biomarkers were measured. Transthoracic echocardiography was performed for pulmonary hypertension assessment via measurement of tricuspid regurgitant jet velocity and was repeated when possible after resolution.
Measurements and main results: Tricuspid jet velocity was less than 2.5 m/second in 34 (40%) of the 84 episodes, 2.5 to 2.9 m/second in 19 (23%), and 3 m/second or greater in 31 episodes (37%). Cor pulmonale occurred in 11 (13%) episodes. Tricuspid jet velocity showed significant positive correlations with B-type natriuretic peptide (rho = 0.54, P < 0.01) and cardiac troponin I (rho = 0.42, P < 0.01). Pulmonary pressures increased compared with steady state then decreased after resolution. All five patients who required invasive ventilation and all four patients who died during the immediate hospital course had jet velocity values of 3 m/second or greater. Overall mortality was 12.9% (9 patients) and survival was significantly lower in patients whose jet velocity was 3 m/second or greater during at least one episode, compared with the other patients (P < 0.01).
Conclusions: Pulmonary pressures increase during severe acute chest syndrome, and pulmonary hypertension is associated with cardiac biomarker elevation and a higher risk of death.
Similar articles
-
A hemodynamic study of pulmonary hypertension in sickle cell disease.N Engl J Med. 2011 Jul 7;365(1):44-53. doi: 10.1056/NEJMoa1005565. N Engl J Med. 2011. PMID: 21732836
-
Elevation of tricuspid regurgitant jet velocity, a marker for pulmonary hypertension in children with sickle cell disease.Pediatr Blood Cancer. 2006 Dec;47(7):907-13. doi: 10.1002/pbc.20791. Pediatr Blood Cancer. 2006. PMID: 16496290
-
Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease.Pediatrics. 2008 Apr;121(4):777-82. doi: 10.1542/peds.2007-0730. Pediatrics. 2008. PMID: 18381543
-
Pulmonary hypertension in children with sickle cell disease.Expert Rev Respir Med. 2011 Apr;5(2):233-43. doi: 10.1586/ers.11.6. Expert Rev Respir Med. 2011. PMID: 21510733 Review.
-
Pulmonary hypertension in sickle cell disease: mechanisms, diagnosis, and management.Hematol Oncol Clin North Am. 2005 Oct;19(5):881-96, vii. doi: 10.1016/j.hoc.2005.07.007. Hematol Oncol Clin North Am. 2005. PMID: 16214649 Review.
Cited by
-
Childhood acquired heart diseases in Jos, north central Nigeria.Niger Med J. 2013 Jan;54(1):51-8. doi: 10.4103/0300-1652.108897. Niger Med J. 2013. PMID: 23661900 Free PMC article.
-
Cardiovascular abnormalities in sickle cell disease.J Am Coll Cardiol. 2012 Mar 27;59(13):1123-33. doi: 10.1016/j.jacc.2011.10.900. J Am Coll Cardiol. 2012. PMID: 22440212 Free PMC article. Review.
-
Antibiotics for treating acute chest syndrome in people with sickle cell disease.Cochrane Database Syst Rev. 2019 Sep 18;9(9):CD006110. doi: 10.1002/14651858.CD006110.pub5. Cochrane Database Syst Rev. 2019. PMID: 31531967 Free PMC article.
-
Myocardial infarction in sickle cell disease: use of translational imaging to diagnose an under-recognized problem.J Cardiovasc Transl Res. 2013 Oct;6(5):752-61. doi: 10.1007/s12265-012-9426-z. Epub 2012 Nov 21. J Cardiovasc Transl Res. 2013. PMID: 23179134 Free PMC article. Review.
-
Sickle Cell Disease and Its Respiratory Complications.Cureus. 2022 Aug 29;14(8):e28528. doi: 10.7759/cureus.28528. eCollection 2022 Aug. Cureus. 2022. PMID: 36185937 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials